Mission
The Tobacco Control Research Branch (TCRB) leads and collaborates on research and disseminates evidence-based findings to prevent, treat, and control tobacco use in order to create a world free of tobacco use and related cancer and suffering. TCRB is within the National Cancer Institute’s (NCI) Behavioral Research Program (BRP), in the Division of Cancer Control and Population Sciences (DCCPS).
Scientific Priorities
- Advertising and marketing of tobacco products
- Epidemiology and surveillance of tobacco knowledge, attitudes, and behavior
- Etiology, predictors, correlates, and determinants of tobacco use, nicotine dependence, and cessation
- Global tobacco control, especially in low- and middle-income countries
- Media and policy to reduce tobacco use
- Other tobacco products, e.g., smokeless tobacco, cigars, roll-your-own, hookah, bidis, etc.
- Potential Reduced-Exposure Tobacco Products (PREPs)
- Secondhand smoke
- Tobacco cessation interventions at the individual, system, and population levels
- Tobacco control interventions for underserved and at-risk populations
- Tobacco industry documents
- Tobacco prevention interventions at the individual, system, and population levels
- Tobacco product analysis, e.g., design and composition, constituents and additives, processing, manufacturing
- Tobacco use and cessation in cancer screening, diagnosis, treatment, and survivorship
- Tobacco-related disparities
News and Highlights
- JCO Oncology Practice article – Treating Smoking in Cancer Patients: An Essential Component of Cancer Care-The New National Cancer Institute Tobacco Control Monograph
- FDA Proposes Rule Prohibiting Menthol Cigarettes – Cancer Currents Blog
- Smokefree.gov celebrates 20 years! View and share our social media toolkit and short video.
- Smokefree.gov launches SmokefreeNATIVE. View the Indian Health Service blog post and share our social media toolkit.
Featured Funding Announcement
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities
PAR-23-270 (R01 Clinical Trial Required)
See More AnnouncementsResearch Areas
Grant Portfolio and Funding Opportunities
Featured Grantees
Stella A. Bialous, DrPH, FAAN
Understanding how tobacco industry's target marketing, co-option of civil and political leaders, and misinformation provide a road map to develop policies and programs that can effectively counter these activities and address disparities.”Stella A. Bialous, DrPH, FAAN
Daniel P. Giovenco, PhD, MPH
Tobacco use is now unjustly concentrated among socially and economically disadvantaged populations and poses one of the most urgent threats to public health and social justice. I am deeply motivated to continue this line of work until tobacco use no longer poses a major threat to population health and society. ”Daniel P. Giovenco, PhD, MPH
Sterling M. McPherson, PhD
I came into the area tobacco control by way of observing that a high percentage of our participants in clinical trials of alcohol, methamphetamine and opioid use smoke.”Sterling M. McPherson, PhD
Resources
Meet Our Staff
Our team of accomplished scientists and research associates, fellows, and administrators is dedicated to advancing behavioral science research in cancer prevention and control.
TCRB Staff